Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 478-5685

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

02.03.2020 - 04.03.2020

EACR-AACR-ASPIC 2020 Conference: Tumor Microenvironment

Location
Lisbon Congress Centre, Lisbon
Contact

For queries relating to registration, abstracts and Visas, please contact Covr - eaa2020@covr.be


For all other queries, please contact Wessel Nieuwenweg - hello@eaa2020.org

Country
Portugal
Subject area(s)
Shortinfo

The European Association for Cancer Research (EACR), American Association for Cancer Research (AACR) and Associação Portuguesa de Investigação em Cancro (ASPIC) are proud to announce this new joint Basic and Translational Research Conference on Tumor Microenvironment, to be held in Lisbon, Portugal, 02-04 March 2020.


This EACR-AACR-ASPIC conference on Tumor Microenvironment (TME) will bring together thought leaders spanning the breadth of TME, immune-oncology, computational biology and biomedical technology disciplines to discuss novel approaches to identify critical mechanisms regulating the crosstalk in these tumor ecosystems. We will also discuss therapeutic approaches to target the TME for durable tumor control, including strategies being deployed in patients, and initial clinical findings. The goal will be to not only discuss the current state of the TME field, but also discuss approaches towards applying that knowledge to the development of effective and broadly applicable anti-cancer therapies for long-term management of disease.